Mainz (dpa/lrs) - Microsoft-Gründer Bill Gates hat den Mainzer Impfstoffhersteller Biontech besucht. Er traf bei dem Besuch ...

The headline news in the new agreement is the formation of a joint AI Innovation Lab – split between InstaDeep’s headquarters in London in the UK and BioNTech’s site in Mainz Germany ...

We rate BioNTech SE a hold due to volatile performance, weak growth, and premium valuation amidst COVID-19 vaccine reliance.

Durften Biontech und Pfizer die mRNA-Technologie der US-Konkurrenz auf Dauer lizenzfrei nutzen? Moderna überzieht das Mainzer ...

More about BioNTech SE BioNTech SE is a biotechnology company based in Mainz, Germany, primarily known for its development of mRNA-based vaccines and immunotherapies. The company is a significant ...

Durften Biontech und Pfizer die mRNA-Technologie der US-Konkurrenz auf Dauer lizenzfrei nutzen? Moderna überzieht das Mainzer ...

BioNTech SE operates as immunotherapy company ... 2008 and is headquartered in Mainz, Germany.

BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. Fintel is one of ...

MAINZ, Germany, January 14, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today will present its 2025 strategic priorities and progress on the Company ...

Microsoft-Gründer Bill Gates hat den Mainzer Impfstoffhersteller Biontech besucht. Er traf bei dem Besuch am vergangenen Montag unter anderem die beiden Biontech-Mitbegründer Ugur Sahin und ...

https://www.tipranks.com/news/the-fly/si-bone-price-target-raised-to-20-from-19-at-needham BioNTech SE ( (BNTX) ) has provided an update. BioNTech SE has settled a ...